Opus Point Partners Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Opus Point Partners Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$423K	Hold	3,674	–	–	0.76%	34
2019 Q2	$633K	Hold	3,674	–	–	0.94%	28
2019 Q1	$619K	Buy	+3,674	New	+$547K	0.84%	27

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Opus Point Partners Management's GWPH Position: Q3 2019 in Review

Opus Point Partners Management held its GW Pharmaceuticals Plc American Depositary Shares (GWPH) position steady in Q3 2019 at 3,674 shares worth $423K. The position accounts for 0.76% of the portfolio, ranked #34.

Opus Point Partners Management first reported a position in GWPH in Q1 2019 and has held it in 3 quarters since. The position peaked at $633K in Q2 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

Opus Point Partners Management held 3,674 shares of GW Pharmaceuticals Plc American Depositary Shares worth $423K as of Q3 2019.
Opus Point Partners Management left its GW Pharmaceuticals Plc American Depositary Shares share count unchanged in Q3 2019.
GW Pharmaceuticals Plc American Depositary Shares made up 0.76% of Opus Point Partners Management's portfolio in Q3 2019, its #34 holding.
Opus Point Partners Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and has held it in 3 quarters since.
Opus Point Partners Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $633K in Q2 2019.
316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.